Stock ALPMY ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Astellas Pharma Inc. OTC Markets

Equities

ALPMY

US04623U1025

Delayed OTC Markets
Other stock markets
 15:23:57 24/05/2024 BST 		5-day change 1st Jan Change
9.955 USD +0.96% Intraday chart for Astellas Pharma Inc. +5.01% -16.34%
05-21 Astellas Announces Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies CI
05-16 Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea DJ

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. ALPMY Stock
  5. Revisions Astellas Pharma Inc.